Hodges Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Sell |
4,842
-147
| -3% | -$10.1K | 0.03% | 171 |
|
|
2025
Q1 | $346K | Sell |
4,989
-23,225
| -82% | -$1.61M | 0.03% | 185 |
|
|
2024
Q4 | $3.72M | Sell |
28,214
-60,012
| -68% | -$7.91M | 0.22% | 115 |
|
|
2024
Q3 | $10.5M | Sell |
88,226
-9,342
| -10% | -$1.11M | 0.67% | 46 |
|
|
2024
Q2 | $13.9M | Sell |
97,568
-61,490
| -39% | -$8.78M | 0.93% | 28 |
|
|
2024
Q1 | $20.4M | Sell |
159,058
-39,684
| -20% | -$5.1M | 1.3% | 21 |
|
|
2023
Q4 | $20.6M | Buy |
198,742
+121,078
| +156% | +$12.5M | 1.09% | 26 |
|
|
2023
Q3 | $9.08M | Sell |
77,664
-13,644
| -15% | -$1.6M | 1.08% | 27 |
|
|
2023
Q2 | $9.49M | Buy |
91,308
+6,222
| +7% | +$647K | 0.55% | 57 |
|
|
2023
Q1 | $7.72M | Buy |
85,086
+19,992
| +31% | +$1.81M | 0.63% | 50 |
|
|
2022
Q4 | $7.9M | Buy |
65,094
+60,094
| +1,202% | +$7.29M | 0.68% | 48 |
|
|
2022
Q3 | $249K | Hold |
5,000
| – | – | 0.04% | 190 |
|
|
2022
Q2 | $279K | Hold |
5,000
| – | – | 0.03% | 198 |
|
|
2022
Q1 | $278K | Hold |
5,000
| – | – | 0.02% | 214 |
|
|
2021
Q4 | $280K | Hold |
5,000
| – | – | 0.02% | 222 |
|
|
2021
Q3 | $240K | Hold |
5,000
| – | – | 0.02% | 224 |
|
|
2021
Q2 | $209K | Buy |
+5,000
| New | +$209K | 0.02% | 231 |
|